SETD7-mediated H3K4me1 activates ALDH1A3 to drive ferroptosis resistance in esophageal squamous cell carcinoma
8.0
来源：
Nature
关键字：
mRNA
发布时间：
2025-11-08 03:47
摘要：
SETD7, a histone lysine methyltransferase, is significantly overexpressed in esophageal squamous cell carcinoma (ESCC) and correlates with clinical staging. This study demonstrates that SETD7 promotes ESCC cell proliferation and migration while enhancing resistance to ferroptosis through H3K4me1-mediated activation of ALDH1A3. The findings suggest that targeting SETD7 could provide a novel therapeutic strategy for ESCC, a cancer with poor prognosis and limited treatment options.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0
business_impact
1.0
scientific_rigor
1.5
timeliness_innovation
1.5
investment_perspective
2.5
market_value_relevance
1.0
team_institution_background
0.5
technical_barrier_competition
1.0
关键证据
SETD7 expression is significantly upregulated in ESCC tissues and correlates with clinical staging.
SETD7 promotes ESCC cell proliferation and migration in vitro.
SETD7 enhances resistance to ferroptosis in ESCC cells through H3K4me1-mediated upregulation of ALDH1A3.
真实性检查
否
AI评分总结
SETD7, a histone lysine methyltransferase, is significantly overexpressed in esophageal squamous cell carcinoma (ESCC) and correlates with clinical staging. This study demonstrates that SETD7 promotes ESCC cell proliferation and migration while enhancing resistance to ferroptosis through H3K4me1-mediated activation of ALDH1A3. The findings suggest that targeting SETD7 could provide a novel therapeutic strategy for ESCC, a cancer with poor prognosis and limited treatment options.